Skip to content
POM-V Prescription Required Companion Animal

Vivitonin 50 mg Tablets for Dogs

Active ingredient: Propentofylline

Form

Tablet

Species

Dogs

Manufacturer

Intervet International B.V.

VMD MA No.

06376/4074

What it's used for

medicinal product is particularly useful in older dogs, where it may increase willingness to exercise and exercise tolerance.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Propentofylline

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Vivitonin 50 mg Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

medicinal product is particularly useful in older dogs, where it may increase
willingness to exercise and exercise tolerance.
Half a tablet per 5 kg body weight twice a day (equivalent to 6-10 mg propentofylline
per kg bodyweight per day).
Dogs of less than 5 kg may receive a quarter of a tablet twice a day. Dogs of more
than 20 kg can be given Vivitonin 100 mg tablets.
The tablets can be administered directly onto the back of the dog's tongue or can be
mixed in a small ball of food and should be administered at least 30 minutes before
feeding.
Divide the tablets in halves and quarters with a knife or with a tablet splitter.
Do not administer to pregnant bitches or breeding animals.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Dogs:
Rare
(1 to 10 animals / 10,000 animals
treated):
Vomiting
;
Allergic reaction (e.g., Urticaria)
1
Particularly at the commencement of therapy.
Necessitates discontinuation of treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None.

Special precautions for safe use in the target species:
Specific diseases (e.g. kidney disease) should be treated accordingly.
In the case of renal failure, the dose should be reduced.
Consideration should be given to rationalising the medication of dogs already
receiving treatment for congestive heart failure or bronchial disease.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Care should be taken to avoid accidental ingestion.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
None known.
Do not store above 25 °C.
Store in a dry place.
Keep the blister packs in the outer carton.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.